willow health glp 1 Start (@startwillow) • Instagram photos and videos Willow GLP-1 Review 2026: Flat

Conclusion Zepbound, a GLP-1 medication, is becoming a key treatment for moderate sleep apnea

It is particularly effective for individuals with high BMI or co-occurring type 2 diabetes, as these groups often experience significant improvements in both weight and metabolic health

Similarly, Lincoff et al59 conducted an RCT enrolling 17,604 patients aged 45 years or older with pre-existing cardiovascular disease and a BMI of 27 or higher but without a history of diabetes

These stories help normalize the experiencepatients are not alone, and there are options for support

The platform addresses a massive market opportunity at the intersection of the $28.65B global weight loss supplement market and the $39.74B global probiotic drink market, with initial focus on the U.S

This is considered obese